Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin for OAB symptoms in women (RESORT part 2)
NCT02667470Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2009
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Sep 2009; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02667470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02667470.